Stone Ridge Asset Management’s NeoGenomics NEO Stock Holding History

Stone Ridge Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-33,867	Closed	-$1.05M	–	319
2020 Q2	$1.05M	Hold	33,867	–	–	0.17%	102
2020 Q1	$935K	Hold	33,867	–	–	0.1%	220
2019 Q4	$991K	Hold	33,867	–	–	0.06%	395
2019 Q3	$648K	Hold	33,867	–	–	0.04%	571
2019 Q2	$743K	Hold	33,867	–	–	0.04%	538
2019 Q1	$693K	Sell	33,867 -2,466	-7%	-$42.9K	0.04%	577
2018 Q4	$458K	Buy	36,333 +4,266	+13%	+$63.6K	0.03%	816
2018 Q3	$492K	Hold	32,067	–	–	0.03%	856
2018 Q2	$420K	Hold	32,067	–	–	0.02%	874
2018 Q1	$262K	Buy	32,067 +300	+0.9%	+$2.43K	0.02%	1116
2017 Q4	$281K	Buy	+31,767	New	+$293K	0.02%	1088

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Stone Ridge Asset Management's NEO Position: Q3 2020 in Review

Stone Ridge Asset Management sold out of NeoGenomics (NEO) in Q3 2020, closing a stake of 33,867 shares — an estimated $1.05M sold.

Stone Ridge Asset Management first reported a position in NEO in Q4 2017 and held it in 11 quarters. The position peaked at $1.05M in Q2 2020. 294 funds tracked by Wall St. Rank hold NEO as of Q3 2020.

Stone Ridge Asset Management reported no remaining NeoGenomics position as of Q3 2020 after selling out during the quarter.
Stone Ridge Asset Management sold 33,867 NeoGenomics shares in Q3 2020, an estimated $1.05M.
Stone Ridge Asset Management first reported a position in NeoGenomics in Q4 2017 and held it in 11 quarters.
Stone Ridge Asset Management's NeoGenomics position peaked at $1.05M in Q2 2020.
294 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2020.

Based on Stone Ridge Asset Management's 13F filing for Q3 2020.